Veraxa Biotech, a drug discovery and development engine for antibody-drug conjugates (ADCs) and novel antibody-based therapy concepts, and Voyager Acquisition Corp, a US$253m Nasdaq-listed SPAC targeting the healthcare sector, are…
Switzerland: Voyager Acquisition Corp combines with Veraxa for Nasdaq IPO
…
…





